相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune suppression or enhanceme by CD137 T cell costimulation during acute viral infection is time dependent
Benyue Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Phase 1, pharmacokinetic (PK) and pharmacodynamic (PD) study of oral alvespimycin (A; KOS-1022; 17-DMAG): Two different schedules in patients with advanced malignancies
K. T. Flaherty et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody
Robert H. Vonderheide et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Immunostimulatory monoclonal antibodies for cancer therapy
Ignacio Melero et al.
NATURE REVIEWS CANCER (2007)
CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype
Yuwen Zhu et al.
BLOOD (2007)
Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses
Seung-Woo Lee et al.
JOURNAL OF IMMUNOLOGY (2006)
Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity
Ergun Kocak et al.
CANCER RESEARCH (2006)
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206
A Ribas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease
J Lee et al.
IMMUNOLOGY LETTERS (2005)
Cytotoxic T-Lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer
JA Blansfield et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4
P Attia et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Linked foreign T-cell help activates self-reactive CTL and inhibits tumor growth
L Steinaa et al.
JOURNAL OF IMMUNOLOGY (2005)
Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity:: a novel regulatory role for OX40 and its comparison with GITR
B Valzasina et al.
BLOOD (2005)
Cutting edge:: TLR ligands are not sufficient to break cross-tolerance to self-antigens
EE Hamilton-Williams et al.
JOURNAL OF IMMUNOLOGY (2005)
Costimulation of CD8 T cell responses by OX40
P Bansal-Pakala et al.
JOURNAL OF IMMUNOLOGY (2004)
4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function
SJ Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells
GX Zheng et al.
JOURNAL OF IMMUNOLOGY (2004)
The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement
AD Weinberg et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Costimulation of T cells by OX40, 4-1BB, and CD27
M Croft
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function
JM Curtsinger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
FS Hodi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1
HW Lee et al.
JOURNAL OF IMMUNOLOGY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner
RE Miller et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells
T Futagawa et al.
INTERNATIONAL IMMUNOLOGY (2002)
Engagement of the OX-40 receptor in vivo enhances antitumor immunity
AD Weinberg et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
